Clincosm LogoSign in Get a demo

phase 1

Showing 1 - 9 of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Phase 1, Solid Tumor, Adult Trial in Goyang, Seongnam, Seoul (NOV1601(CHC2014))

Completed
  • Phase 1
  • Solid Tumor, Adult
  • Goyang, Gyeonggi-do, Korea, Republic of
  • +3 more
Sep 8, 2021

Phase 1 Trial in Brussels (PF-04965842, Midazolam)

Completed
  • Phase 1
  • Brussels, Belgium
    Pfizer Clinical Research Unit
Mar 19, 2020

Phase 1, Dengue Trial in Adelaide (Dengushield 1 mg/kg (Cohort 1) intravenous, Dengushield 3 mg/kg (Cohort 2) intravenous,

Completed
  • Phase 1
  • Dengue
  • Dengushield 1 mg/kg (Cohort 1) intravenous
  • +6 more
  • Adelaide, South Australia, Australia
    CMAX Clinical Research Pty Ltd
Feb 15, 2020

Phase 1, Multiple Dose, Safety Trial in Bruxelles (UK-396,082, )

Completed
  • Phase 1
  • +4 more
  • Bruxelles, Belgium
    Pfizer Investigational Site
Nov 30, 2018

Phase 1, Bioequivalence Trial in Tehran (Etanercept)

Completed
  • Phase 1
  • Bioequivalence
  • Tehrān, Tehran, Iran, Islamic Republic of
    Orchidpharmed PK/PD site
Sep 18, 2018

Bioequivalence, Phase 1 Trial in Tehran (Adalimumab)

Completed
  • Bioequivalence
  • Phase 1
  • Tehran, Iran, Islamic Republic of
    Orchidpharmed PK/PD site
Sep 18, 2018

Phase 1, Healthy, Benign Prostatic Hyperplasia Trial in Zuidlaren (Tamsulosin HCl, Solifenacin Succinate, EC905)

Completed
  • Phase 1
  • +3 more
  • Tamsulosin HCl
  • +2 more
  • Zuidlaren, Drente, Netherlands
    Site NL1
Dec 16, 2015

Phase 1, Bioavailability, Healthy Subjects Trial in Berlin (solifenacin succinate, mirabegron, mirabegron/solifenacin succinate)

Completed
  • Phase 1
  • +2 more
  • solifenacin succinate
  • +2 more
  • Berlin, Germany
    Parexel
Dec 10, 2013

Phase 1, Single Dose, Safety Trial in Bruxelles (PF-05212372, Placebo)

Completed
  • Phase 1
  • +4 more
  • Bruxelles, Belgium
    Pfizer Investigational Site
Aug 12, 2011